A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

Clinical trial NCT01900652 · COMPLETED

Trial details

NCT number: NCT01900652
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2013-08-01
Primary completion: 2015-02-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.